Bausch And Lomb Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAUSCH AND LOMB, and what generic alternatives to BAUSCH AND LOMB drugs are available?
BAUSCH AND LOMB has eighty-two approved drugs.
There are forty-nine US patents protecting BAUSCH AND LOMB drugs.
There are four hundred and seventy-one patent family members on BAUSCH AND LOMB drugs in forty-seven countries and eighty supplementary protection certificates in fifteen countries.
Summary for Bausch And Lomb
| International Patents: | 471 |
| US Patents: | 49 |
| Tradenames: | 75 |
| Ingredients: | 58 |
| NDAs: | 82 |
Drugs and US Patents for Bausch And Lomb
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | XIPERE | triamcinolone acetonide | SUSPENSION;INJECTION | 211950-001 | Oct 22, 2021 | RX | Yes | Yes | 8,636,713 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Bausch And Lomb | PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | SOLUTION/DROPS;OPHTHALMIC | 040065-001 | Jul 29, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Bausch And Lomb | NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE | bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 064068-001 | Oct 30, 1995 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Bausch And Lomb | VITRASERT | ganciclovir | IMPLANT;IMPLANTATION | 020569-001 | Mar 4, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Bausch And Lomb Inc | LUMIFY | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 208144-001 | Dec 22, 2017 | OTC | Yes | Yes | 11,596,600 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bausch And Lomb
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch And Lomb | ISTALOL | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 021516-001 | Jun 4, 2004 | 6,335,335 | ⤷ Try a Trial |
| Bausch And Lomb | BESIVANCE | besifloxacin hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 022308-001 | May 28, 2009 | 6,685,958 | ⤷ Try a Trial |
| Bausch And Lomb | ZYLET | loteprednol etabonate; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050804-001 | Dec 14, 2004 | 4,996,335*PED | ⤷ Try a Trial |
| Bausch And Lomb | RETISERT | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 021737-001 | Apr 8, 2005 | 6,217,895 | ⤷ Try a Trial |
| Bausch And Lomb | BESIVANCE | besifloxacin hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 022308-001 | May 28, 2009 | 5,447,926 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BAUSCH AND LOMB drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.07% | ➤ Subscribe | 2013-07-26 |
| ➤ Subscribe | Ophthalmic Solution | 0.5% | ➤ Subscribe | 2012-10-19 |
| ➤ Subscribe | Ophthalmic Solution | 1.5% | ➤ Subscribe | 2013-09-09 |
International Patents for Bausch And Lomb Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2018127485 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2017220625 | ⤷ Try a Trial |
| South Korea | 102538370 | ⤷ Try a Trial |
| Spain | 2767136 | ⤷ Try a Trial |
| Eurasian Patent Organization | 200601099 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bausch And Lomb Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0509752 | C990041 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DORZOLAMIDE, DESGEWENST IN DE VORM VAN EEN OFTALMOLOGISCH AAN- VAARDBAAR ZOUT, EN TIMOLOL, DESGEWENST IN DE VORM VAN EEN OFTAL -MOLOGISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER DORZOLLAMIDEHY- DROCHLORIDE EN TIMOLOLMALEAAT, EEN EN ANDER ZODANIG DAT 0,05; NATL REGISTRATION NO/DATE: VG 22871 19980805; FIRST REGISTRATION: DK 19045 19980306 |
| 0206283 | C980016 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: LEVOFLOXACINE, DESGEWENST IN DE VORM VAN EEN SOLVAAT, IN HET BIJZONDER LEVOFLOXACINE-HEMIHYDRAAT; NAT. REGISTRATION NO/DATE: RVG 21810 - RVG 21812 19971209; FIRST REGISTRATION: GB 13402/0011 - 13402/0013 19970606 |
| 0957929 | CA 2006 00021 | Denmark | ⤷ Try a Trial | PRODUCT NAME: PEGAPTANIB, NATRIUM |
| 2826776 | CA 2021 00013 | Denmark | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF (A) (R)-1-(2,2-DIFLUOROBENZO(D)(1,3)DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANECARBOXAMIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND (B) ....; REG. NO/DATE: EU/1/18/1306 20181106 |
| 1586316 | 11C0031 | France | ⤷ Try a Trial | PRODUCT NAME: BROMFENAC, SES SELS OU HYDRATES PHARMACOLOGIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/11/692/001 20110518 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
